{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T02:13:39Z","timestamp":1793240019370,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,9]],"date-time":"2023-02-09T00:00:00Z","timestamp":1675900800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jbc.2023.103004","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T17:02:47Z","timestamp":1676048567000},"page":"103004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"title":["Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease"],"prefix":"10.1016","volume":"299","author":[{"given":"Gabriela Dias","family":"Noske","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"de Souza Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4492-1330","authenticated-orcid":false,"given":"Mariana Ortiz","family":"de Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2431-0383","authenticated-orcid":false,"given":"Isabela","family":"Dolci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela Sachetto","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7187-0818","authenticated-orcid":false,"given":"Rafael Vict\u00f3rio Carvalho","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6768-0536","authenticated-orcid":false,"given":"Peter","family":"Sj\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-0302","authenticated-orcid":false,"given":"Glaucius","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0613-9164","authenticated-orcid":false,"given":"Andre Schutzer","family":"Godoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.103004_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A\u00a0pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.103004_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A\u00a0new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.103004_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.103004_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/s41586-020-2739-1","article-title":"The coding capacity of SARS-CoV-2","volume":"589","author":"Finkel","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.103004_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-19662-4","article-title":"Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.103004_bib6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41594-020-0440-6","article-title":"Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur","volume":"27","author":"Jin","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2023.103004_bib7","doi-asserted-by":"crossref","first-page":"167118","DOI":"10.1016\/j.jmb.2021.167118","article-title":"A\u00a0crystallographic snapshot of SARS-CoV-2 main protease maturation process","volume":"433","author":"Noske","year":"2021","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2023.103004_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41589-020-00689-z","article-title":"SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging","volume":"17","author":"Rut","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2023.103004_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18233-x","article-title":"Both boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.103004_bib10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2023.103004_bib11","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1021\/acs.jmedchem.2c00624","article-title":"S-217622, a 3CL protease inhibitor and clinical candidate for SARS-CoV-2","volume":"65","author":"Tyndall","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2023.103004_bib12","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1021\/acs.jmedchem.2c00117","article-title":"Discovery of S-217622, a noncovalent oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19","volume":"65","author":"Unoh","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2023.103004_bib13","article-title":"Open science discovery of oral non-covalent SARS-CoV-2 main protease inhibitor therapeutics","author":"Achdout","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2023.103004_bib14","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.103004_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-03090-9","article-title":"Identification of SARS-CoV-2 inhibitors targeting Mpro and PLpro using in-cell-protease assay","volume":"5","author":"Narayanan","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jbc.2023.103004_bib16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jbc.2023.103004_bib17","doi-asserted-by":"crossref","first-page":"777212","DOI":"10.3389\/fcimb.2021.777212","article-title":"SARS-CoV-2: emergence of new variants and effectiveness of vaccines","volume":"11","author":"Singh","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.jbc.2023.103004_bib18","doi-asserted-by":"crossref","first-page":"809244","DOI":"10.3389\/fimmu.2021.809244","article-title":"SARS-CoV-2 variants, vaccines, and host immunity","volume":"10","author":"Mistry","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2023.103004_bib19","first-page":"470226","article-title":"Main protease mutants of SARS-CoV-2 variants remain susceptible to nirmatrelvir","volume":"10","author":"Ullrich","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.jbc.2023.103004_bib20","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/iub.2465","article-title":"Identification of mutation resistance coldspots for targeting the SARS-CoV2 main protease","volume":"73","author":"Krishnamoorthy","year":"2021","journal-title":"IUBMB Life"},{"key":"10.1016\/j.jbc.2023.103004_bib21","doi-asserted-by":"crossref","first-page":"101972","DOI":"10.1016\/j.jbc.2022.101972","article-title":"Structural basis for the in\u00a0vitro efficacy of nirmatrelvir against SARS-CoV-2 variants","volume":"298","author":"Greasley","year":"2022","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.103004_bib22","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.46234\/ccdcw2021.255","article-title":"GISAID\u2019s role in pandemic response","volume":"3","author":"Khare","year":"2021","journal-title":"China CDC Wkly."},{"key":"10.1016\/j.jbc.2023.103004_bib23","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.chom.2022.08.003","article-title":"Functional map of SARS-CoV-2 3CL protease reveals tolerant and immutable sites","volume":"30","author":"Iketani","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jbc.2023.103004_bib24","article-title":"Naturally occurring mutations of SARS-CoV-2 main protease confer drug resistance to nirmatrelvir","author":"Hu","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2023.103004_bib25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41586-022-05514-2","article-title":"Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir","volume":"613","author":"Iketani","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2023.103004_bib26","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1021\/acs.biochem.2c00489","article-title":"Predicting antiviral resistance mutations in SARS-CoV-2 main protease with computational and experimental screening","volume":"61","author":"Sasi","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.103004_bib27","article-title":"H172Y mutation perturbs the S1 pocket and nirmatrelvir binding of SARS-CoV-2 main protease through a nonnative hydrogen bond","author":"de Oliveira","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.jbc.2023.103004_bib28","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.bbrc.2022.09.010","article-title":"Hotspot residues and resistance mutations in the nirmatrelvir-binding site of SARS-CoV-2 main protease: design, identification, and correlation with globally circulating viral genomes","volume":"629","author":"Padhi","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jbc.2023.103004_bib29","doi-asserted-by":"crossref","first-page":"6069","DOI":"10.1093\/nar\/18.20.6069","article-title":"Ligation-independent cloning of PCR products (LIC-PCR)","volume":"18","author":"Aslanidis","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2023.103004_bib30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.pep.2005.01.016","article-title":"Protein production by auto-induction in high density shaking cultures","volume":"41","author":"Studier","year":"2005","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.jbc.2023.103004_bib31","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1038\/s41467-020-18709-w","article-title":"Crystallographic and electrophilic fragment screening of the SARS-CoV-2 main protease","volume":"11","author":"Douangamath","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.103004_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1107\/S0907444911007773","article-title":"Data processing and analysis with the autoPROC toolbox","volume":"67","author":"Vonrhein","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2023.103004_bib33","doi-asserted-by":"crossref","first-page":"a360","DOI":"10.1107\/S010876731809640X","article-title":"Advances in automated data analysis and processing within autoPROC, combined with improved characterisation, mitigation and visualisation of the anisotropy of diffraction limits using STARANISO","volume":"74","author":"Vonrhein","year":"2018","journal-title":"Acta Crystallogr. A Found. Adv."},{"key":"10.1016\/j.jbc.2023.103004_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.sbi.2015.07.003","article-title":"Assessing and maximizing data quality in macromolecular crystallography","volume":"34","author":"Karplus","year":"2015","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.jbc.2023.103004_bib35","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1126\/science.1218231","article-title":"Linking crystallographic model and data quality","volume":"336","author":"Karplus","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.103004_bib36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2023.103004_bib37","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S2059798317000067","article-title":"AceDRG: a stereochemical description generator for ligands","volume":"73","author":"Long","year":"2017","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2023.103004_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1107\/S2059798317016035","article-title":"CCP4i2: the new graphical user interface to the CCP4 program suite","volume":"74","author":"Potterton","year":"2018","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2023.103004_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"Murshudov","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2023.103004_bib40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2023.103004_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2023.103004_bib42","doi-asserted-by":"crossref","first-page":"W441","DOI":"10.1093\/nar\/gkp253","article-title":"IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding","volume":"37","author":"Cer","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2023.103004_bib43","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/pro.3280","article-title":"Improvements to the APBS biomolecular solvation software suite","volume":"27","author":"Jurrus","year":"2018","journal-title":"Protein Sci."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823001369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823001369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:41:14Z","timestamp":1758242474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823001369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0021925823001369"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.103004","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 main protease","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.103004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 THE AUTHORS. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"103004"}}